What You Should Know:
- Weave Bio, an AI-native life sciences platform company, announced today the public release of its flagship offering, AutoIND, and $10 million in seed funding co-led by Innovation Endeavors and Magnetic Ventures.
- AutoIND marks a significant advancement in drug development by automating and accelerating the preparation, writing, and review process for Investigational New Drug (IND) applications.
Automating the IND Process: A Game-Changer for Drug
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
CVS + Echo Health Makes Strategic Investment in Thyme Care
What You Should Know:
- Thyme Care, a leader in value-based cancer care, has announced a strategic investment from Echo Health Ventures and CVS Health Ventures. Both partners have identified Thyme Care’s provider-centric approach as the only way to improve the patient experience and reduce costs across the care continuum. The investment was part of Thyme’s Series B fundraise.
- The strategic funding will fuel the national expansion of Thyme Care's innovative model, aiming to improve
Read More
Boulder Care Secures $35M to Expand Telehealth Addiction Treatment for Underserved Communities
What You Should Know:
- Boulder Care, a leading provider of high-quality addiction treatment, announced today the successful closing of an oversubscribed $35M Series C funding round led by Advance Venture Partners (AVP), joined by Stripes and existing investors, including First Round Capital, Qiming Venture Partners, and Laerdal Million Lives Fund.
- Boulder Care will invest in developing even more robust services tailored to address the specific needs of high-need patients and plans
Read More
OncoveryCare Secures $4.5M to Launch Novel Cancer Survivorship Model
What You Should Know:
- OncoveryCare (formerly VivorCare) has closed an oversubscribed $4.5 million seed financing to launch its novel cancer survivorship care model.
- The fundraise was led by .406 Ventures alongside the McKay Institute for Oncology Transformation at Tennessee Oncology. Tennessee Oncology, which treats half of Tennessee’s cancer patients at 35 sites, is also a founding member of OneOncology, a
Read More
Tuesday Health Launches Supportive Care Solution with $60M
What You Should Know:
- Tuesday Health, a leader in value-based care for the seriously ill, has launched its innovative supportive care solution with $60M in partnership with Valtruis, Blue Venture Fund, Mass General Brigham Ventures, and CareSource.
- Tuesday Health's mission is to make the end-of-life journey clearer and more supportive for patients and families. With this significant investment and a committed team, they are well-positioned to achieve their goals and
Read More
SamaCare Secures $17M to Scale Specialty Drug Prior Authorization Platform
What You Should Know:
- SamaCare, a cloud-based patient access platform for specialty medications, today announced that it has closed an oversubscribed $17 million Series B investment round led by new investor Questa Capital.
- Questa is joined in the round by existing investors Vive Collective and South Park Commons.
SamaCare
Read More
Videra Health Secures 5.6M for AI-Powered Mental Health Screening & Monitoring
What You Should Know:
- Videra Health, a frontrunner in AI-powered mental health assessments raises $5.6M in Seed II funding led by Peterson Ventures, with participation from Mercato Partners, Epic Ventures, and Philo Ventures.
- Videra Health aims to tackle these challenges by offering widespread, streamlined mental health screening and monitoring powered by AI technology.
Transforming Mental Health Screening with Video Technology
Videra Health leverages cutting-edge
Read More
Daffodil Health Secures $4.6M for AI-Powered Healthcare Pricing & Admin Solution
What You Should Know:
- Daffodil Health, a healthcare technology company, has secured $4.6M in seed funding to tackle the multi-billion dollar problem of wasted healthcare administrative costs led by Maverick Ventures with participation from Epic Ventures.
- Daffodil Health is the brainchild of a team with over 100 years of combined experience in healthcare and technology, from companies like MultiPlan, Google, and McKinsey. They recognize the urgent need to overhaul the current
Read More
Phenomix Sciences Raises $7.8M to Acclerate Obesity Precision Medicine Adoption
What You Should Know:
- Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, has secured $5.5 million in Series A funding from new investors, DexCom, Inc. and Labcorp, and existing investors, including Health2047.
- The company has also been awarded a $2.3 million Phase II Small Business Innovation Research (SBIR) Grant
Read More
Accenture Backs Turbine’s AI-Powered Platform to Accelerate Drug Discovery
What You Should Know:
- Accenture Ventures, the venture capital arm of Accenture, has announced a strategic investment in Turbine, a company pioneering the use of predictive cell simulations for drug development.
- The investment aims to empower Turbine in extending its innovative technology to global biopharmaceutical companies seeking to unlock hidden biological insights and accelerate crucial drug development processes.
Optimizing Drug Discovery with Simulated
Read More
